Irish clinical trials on the rise: how research growth in 2025-2026 is turning into patient benefit
Industry-sponsored clinical trials in Ireland grew 44% year on year in 2025, and a new national research strategy is now targeting further growth, more patient access and stronger commercial spin-off.
RCSI research could spare breast cancer patients from unnecessary chemotherapy
A new RCSI and UCD study has identified immune markers that could help doctors work out which breast cancer patients are unlikely to benefit from chemotherapy, sparing them from a tough treatment they don't need.
The Irish Blood Test Breakthrough Bringing Faster Alzheimer's Diagnosis Closer
Researchers at Trinity College Dublin and Tallaght University Hospital have shown blood tests can detect and even help predict how Alzheimer's disease progresses - a shift that could end reliance on invasive spinal taps.
150 Patients and Counting: How CAR-T Cell Therapy Is Expanding Across Ireland
Five years after Ireland's first CAR-T infusion, more than 150 patients have now received the personalised blood cancer treatment - and a second national centre is opening in Galway.
From Diet to New Drug Targets: How Irish IBD Research Is Moving Forward in 2026
Irish clinicians and scientists are behind real advances in treating Crohn's disease and ulcerative colitis this year, from a food-based therapy for children to precision-medicine tools that test drugs on a patient's own gut tissue.
AI Is Starting to Read Irish Hearts: Cardiology's New AI Tools in 2025-2026
From a national AI health strategy to Irish-backed cardiac devices attracting tens of millions in funding, artificial intelligence is quietly becoming part of how heart conditions are screened, mapped and monitored in Ireland.